SEC Filing Summary for ADC Therapeutics SA

This filing details transactions by Victor Sandor, a director at ADC Therapeutics SA. On June 1, 2026, Mr. Sandor was granted 45,000 restricted stock units (RSUs) under the Issuer's 2019 Equity Incentive Plan, vesting on the earlier of one year from the grant date or the 2027 Annual Meeting of Shareholders, contingent upon continued service. Each RSU represents a contingent right to one share of the Issuer's common stock. Subsequently, on June 3, 2026, 12,600 shares were withheld by the Issuer to cover tax obligations arising from the vesting of previously granted RSUs. Following these transactions, Mr. Sandor's post-transaction share count is 140,686.